The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263.
Lowe's
LOW · a US exchange · USD · Market cap $112.7B · 167,000 employees
Lowe's Companies, Inc., together with its subsidiaries, operates as a home improvement retailer in the United States and Canada.
FAIL · Does not pass the screenAt the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Lowe's holds its Markdown at $200.80. Elevated stress, defensive posture warranted, held for 3 days.
| Phase | Markdown · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 3 days |
| Price at the screen | $200.80 |
| Valuation | 16.96 trailing · 15.40 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.85 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 82.52% | Below 33% | Interest-bearing debt is 82.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 3.83% | Below 49% | Money owed to the company is 3.8% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.14% | Below 5% | Only 0.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 13% discount to our $225.87 fair value, 8.30% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 12.5% margin of safety to the base estimate.
Third-party analyst targets: 33 covering, consensus Buy. The average target sits +27% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsHome Renovations and Hidden Debt Risks
When you picture a bustling home improvement store, Lowe's is likely what comes to mind. It's the go-to place for everything from construction and maintenance to repair and remodeling, a one-stop-shop for the home enthusiast and professional alike. The company's revenue growth of 10%, solid profit margin of 8%, and a consensus buy rating with a target price north of $258, might seem enticing. But there's a catch - and it's a big one.
Despite the allure of Lowe's robust growth and strong market position, our fair value sits at $232.01, just a 7% premium over the current price. This suggests that while the stock isn't overpriced, it doesn't offer a compelling margin of safety. What makes us wary is the company's debt ratio, which has caused it to fail our ethical screen. Debt in and of itself isn't a death knell, but when it crosses the line into irresponsible territory, it's a red flag we can't ignore.
The risk here is clear: Lowe's debt levels are a concern, and this is a cyclical stock with a forward P/E of 16.5x, which might look appealing but could be masking peak earnings - a classic cyclical value trap. The market's optimism might be overlooking the underlying financial health, and that's a gamble we're not willing to take. Analysis, not advice.
| Forward P/E | 15.4xpriced for continued growth |
| Trailing P/E | 17.0xreasonably valued |
| EPS, trailing | 11.84 |
| EPS, forward | 13.04 |
| Revenue growth | +8.3%steady growth |
| Profit margin | 7.3%thin but positive margins |
| FCF yield | 4.10% |
| Dividend yield | 209.00% |
| Current ratio | 1.11adequate liquidity, worth monitoring |
| Beta | 0.85steadier than the market |
| Short interest, float | 0.02% |
| 52-week range | 199.34 - 293.06 |
| Market cap | $112.7B |
| Employees | 167,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeLOW trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Lowe's (LOW) Laps the Stock Market: Here's Why Zacks · 4 Aug 2026
- Should Investors Buy Tecnoglass for Growth Despite Margin Pressure? Zacks · 4 Aug 2026
- Is Lowe's (LOW) a Buy as Wall Street Analysts Look Optimistic? Zacks · 4 Aug 2026
- What a $101.5 Billion Trade Deficit Really Means for Americans in 2026 24/7 Wall St. · 31 Jul 2026
- 2 Large-Cap Stocks to Target This Week and 1 We Avoid StockStory · 31 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | PRYOR JULIETTE WILLIAMS | Officer | 5,141 | · | |
| 2026-04-01 | BOLTZ WILLIAM P. | Officer | 9,535 | · | |
| 2026-04-01 | GODBOLE SEEMANTINI P | Chief Technology Officer | 9,145 | · | |
| 2026-04-01 | GRIGGS DAN CLAYTON JR. | Officer | 1,526 | · | |
| 2026-04-01 | SINK BRANDON J. | Chief Financial Officer | 8,349 | · | |
| 2026-04-01 | DUPRE JANICE M. | Officer | 5,185 | · | |
| 2026-04-01 | VANCE QUONTA D | Officer | 4,793 | · | |
| 2026-04-01 | VAGELL MARGRETHE R | Officer | 4,653 | · | |
| 2026-04-01 | MCFARLAND JOSEPH MICHAEL III | Officer | 9,535 | · | |
| 2026-04-01 | ELLISON MARVIN R | Chief Executive Officer | 37,292 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 7 Jul2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 3 Aug2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 3 Aug2026 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $226.06 | -4.6% | · | $954 | -4.6% |
| 2 months | $243.05 | -11.3% | $1.20 | $892 | -10.8% |
| 3 months | $238.31 | -9.5% | $1.20 | $910 | -9.0% |
| 6 months | $245.79 | -12.3% | $2.40 | $887 | -11.3% |
| 1 year | $220.55 | -2.2% | $4.80 | $1,000 | 0.0% |
| 2 years | $209.93 | +2.7% | $9.40 | $1,072 | +7.2% |
| 3 years | $197.23 | +9.4% | $13.80 | $1,163 | +16.3% |
| 5 years | $173.55 | +24.3% | $21.20 | $1,365 | +36.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever LOW does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.